Kenyan Health Patient Information Leaflet
Vaccine / immunological product
Prophylaxis against cholera caused by V. cholerae 01. Clinical selection for Cholera Vaccine (parenteral) should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Vaccine / immunological product. Confirm site-specific dose, duration and monitoring before prescribing.
Adult and children over 10 yrs: S.C or I.M, 2 doses of 0.5ml administered at intervals of 1-4 wks. Booster dose: 0.5 ml 6 monthly. Children 5-10 yrs: S.C or I.M, 2 doses of 0.3 ml administered at intervals of 1-4 wks. Booster dose: 0.3 ml 6 monthly. Children 6 months to 5 yrs: S.C or I.M, 2 doses of 0.2ml administered at intervals of 1-4 wks. Booster dose: 0.2ml 6 monthly.Below 6 months.
Local pain, low-grade fever, myalgia. Serious: anaphylaxis, vaccine-specific rare events (e.g. intussusception historically with some rotavirus products).
Store as labelled. Keep out of reach of children.